AMERIPRISE FINANCIAL INC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$99,000
-26.7%
10,707
-7.6%
0.00%
Q3 2020$135,000
-39.5%
11,583
+39.7%
0.00%
Q2 2020$223,000
+156.3%
8,292
-29.4%
0.00%
Q1 2020$87,000
+40.3%
11,743
-38.0%
0.00%
Q4 2019$62,000
+63.2%
18,938
+1.4%
0.00%
Q3 2019$38,000
-11.6%
18,683
+27.2%
0.00%
Q2 2019$43,000
-21.8%
14,6830.0%0.00%
Q1 2019$55,000
-16.7%
14,683
+23.8%
0.00%
Q3 2018$66,000
-21.4%
11,857
-44.4%
0.00%
Q2 2018$84,000
+20.0%
21,344
+104.6%
0.00%
Q4 2015$70,000
-1.4%
10,430
-15.6%
0.00%
Q3 2015$71,000
-47.8%
12,360
-26.1%
0.00%
Q2 2015$136,000
+13.3%
16,720
+13.9%
0.00%
Q1 2015$120,000
-13.7%
14,675
-3.0%
0.00%
Q4 2014$139,000
-71.3%
15,132
-69.3%
0.00%
Q3 2014$485,000
+133.2%
49,352
+155.8%
0.00%
Q2 2014$208,00019,2930.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders